These in vitro data suggest that Notch1 acts as an oncogene in glioma, which has been confirmed in an intracranial xenograft model, where mice injected with control U251MG cells died sooner as compared to mice that received cells in which Notch1 or Dll1 were downregulated by siRNA. The gene discussed is DLL1; the disease is central nervous system cancer.